Worldwide Burden of Gynecological Cancer
Cancer incidence , mortality, and prevalence are commonly used indicators of cancer burden. Estimation of cancer burden is valuable for the formulation of cancer control policies and planning health services. The sources and methods of estimation of glo
- PDF / 760,076 Bytes
- 22 Pages / 439.37 x 666.142 pts Page_size
- 82 Downloads / 157 Views
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 804
2 Indices of Cancer Burden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 805 2.1 Sources and Methods of Estimation of Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 805 3 3.1 3.2 3.3 3.4
The 2005 Estimates of Gynecological Cancer Burden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 807 Cancer of the Uterine Cervix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 807 Cancer of the Uterine Corpus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810 Ovarian Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 812 Other Gynecological Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 814
4
Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 814 Summary Points . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 822
#
Springer Science+Business Media LLC 2010 (USA)
804
46
Worldwide Burden of Gynecological Cancer
Abstract: > Cancer incidence, mortality, and > prevalence are commonly used indicators of cancer burden. Estimation of cancer burden is valuable for the formulation of cancer control policies and planning health services. The sources and methods of estimation of global data and the worldwide burden of gynecological cancers (malignant neoplasm of uterine cervix, corpus, ovary, vagina, vulva, and placenta) are described. Cervical cancer accounted for 487,300 new cases and 269,500 deaths; uterine corpus cancer for 233,300 new cases and 61,400 deaths; ovarian cancer for 230,000 new cases and 140,100 deaths; cancers of the vagina, vulva, placenta, and ill-defined sites together constituted 74,900 cases. Less developed countries accounted for more than 80% of the cervical cancer cases while almost 60% of uterine corpus cases occurred in the developed world. Earnest implementation of current developments in screening and vaccination has the potential to dramatically reduce the burden of cervical cancer. The differences in the outcome of cancer treatment across the world are due to vast disparities in health service infrastructures, human resources, service delivery, and accessibility to services. A significant proportion of patients are unable to access and avail or complete preventive, diagnostic, and therapy services in many countries due to inadequate health care services and financing. Formulation and translation of appropriate cancer control policies an
Data Loading...
